Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Post by rejajon Mar 28, 2024 11:33am

One conference call - much to discuss

The comments related to Labs Q4 and Full Year results have been very interesting.  The full spectrum of reactions and emotions are all there as would be expected given the details provided in the ...more  
Post by alleyesonmeon Mar 28, 2024 11:29am

Additional revenue sources 2024.

Earnings call pidduck said they signed multiple B2B contracts which could lead to 10m annualized with more in the works....dronabinol already at 1.5m this year...this potentially adds 16m annually ...more  
Comment by subaru1on Mar 28, 2024 11:07am

RE:RE:RE:RE:If you haven’t listened to Earnings call…

Totally agree with you and the stock price is reflecting exactly it. First qrt should show around 11 millions of revenue and Ebitda around (500k) if there is a change in tht taxes we will become EPS ...more  
Comment by okgonowon Mar 28, 2024 9:57am

RE:RE:RE:RE:RE:If you haven’t listened to Earnings call…

when did anyone say anything about a RS did i miss something????? also $.09 seems to be the new $.07..... hope this dosent go on for as long as the $.07 lasted
Post by subaru1ion Mar 28, 2024 9:55am

News from DEA today or tomorrow?

U.S. Federal government is open on Friday, including DEA.   I can understand the 'rush' on this earings announcment and CC.  
Comment by lscfaon Mar 28, 2024 9:52am

RE:Potential benefit of Tax cuts

A cut to the excise tax would flow100% to the bottom line.  April 16 federal budget better have some good news otherwise feds will bankrupt the industry and return it to the black market.
Post by subaru1ion Mar 28, 2024 9:50am

For North America, where LABS is located with their

'traditional' global pharm partner, the REAL value of LABS is unlocked by DEA rescheduling, opening the path for pharmaceuticals to be commercialized after FDA approval.   Management ...more  
Post by Danno13on Mar 28, 2024 9:48am

Potential benefit of Tax cuts

Financial Implications: Let’s consider Village Farms as a case study. The shift to a 10% excise tax rate could trim its annual excise tax bill from C$29.2 million to just  ...more  
Comment by Starkickeron Mar 28, 2024 9:38am

RE:RE:RE:RE:If you haven’t listened to Earnings call…

The moment I hear any mention of RS I am gone.
Comment by QContinuum1on Mar 28, 2024 7:47am

RE:RE:RE:If you haven’t listened to Earnings call…

Exactly this.  And I hope now we can move away from the 52 strong and late stage clinical trial nonsense as they now have put a bullet square in the head of that. That said, the transcript was ...more  
Post by 1hot-techwomanon Mar 28, 2024 7:36am

Take Reform could boost MJ stocks by 300%! Come Apr 16th :)

https://markets.businessinsider.com/news/stocks/canadian-cannabis-companies-could-see-valuations-soar-by-up-to-300-with-tax-reform-new-report-shows-1033197003
Post by 1hot-techwomanon Mar 28, 2024 7:28am

Correction :) Book Value is $0.20 as per TD Bank :)

Medipharm Labs Corp does not pay a dividend. Beta 1.09 EPS $-0.05 Book ...more  
Post by 1hot-techwomanon Mar 28, 2024 7:27am

Current Book Value is $0.10 as per TD Bank !!! :)

Medipharm Labs Corp does not pay a dividend. Beta 1.09 EPS $-0.05 Book ...more